IntegraMed Announces New Attain IVF Multi-Cycle In Vitro Fertilization Treatment Financing Program

PURCHASE, N.Y.--(Business Wire)--
IntegraMed America, Inc. (NASDAQ: INMD), the nation`s leading manager of
specialty outpatient healthcare facilities in the emerging, technology-focused
medical niches of fertility and vein care, today announced that it has expanded
its Attain IVF (In Vitro Fertilization) family of treatment financing offerings
to include the Attain IVF Multi-Cycle Program.

The new Attain IVF Multi-Cycle Program was developed for patients who are
seeking a lower cost option to enter IVF treatment and provides them with up to
four IVF treatment cycles for one up-front discounted fee. The Attain IVF
Multi-Cycle also offers expanded patient eligibility standards, enabling the
enrollment of most patients who have been referred by their physician for IVF
treatment, including those who were not eligible for IntegraMed`s Attain IVF
Refund Program.

Pamela Schumann, President of the Consumer Services Division of IntegraMed
commented, "We are very excited to further expand the array of treatment finance
offerings available through the IntegraMed Fertility Network and remain
committed to providing Attain IVF Program participants course-of-treatment
options and customer care support that will best help them improve their chances
of having children.

"The lower cost Attain IVF Multi-Cycle program meets a growing patient need for
more affordable IVF treatment pricing. While not a refund program, Attain IVF
Multi-Cycle does provide an affordable alternative to pay-as-you-go treatment by
helping to eliminate the anxiety and worry often associated with the cost of IVF
treatment."

The Attain Multi-Cycle Program is initially being offered at the following eight
IntegraMed Fertility Network practices and will be rolled out to the entire
network in the next few months:

* Atlanta Center for Reproductive Medicine
* Center for Reproductive Medicine, Orlando
* Cleveland Clinic
* Dallas IVF
* IVF Florida Reproductive Associates
* Reproductive Endocrinology Associates of Charlotte
* Reproductive Medicine Associates of Michigan
* Reproductive Science Center of the San Francisco Bay Area.

Pioneered by IntegraMed on a nationwide basis, the Attain IVF programs offer
several treatment financing alternatives that enable patients to better manage
the financial commitment associated with undergoing a series of IVF treatments.
For most IVF patients the Attain IVF programs present an opportunity to
significantly increase their chances of success by providing them with the
financial means to stay in treatment longer. For more information about the
Attain IVF Program please visit www.attainivf.com.

About IntegraMed America, Inc.

IntegraMed America, Inc. manages highly specialized outpatient facilities in
emerging, technology-based, niche medical markets and is the leading manager of
fertility centers and vein clinics in the United States. IntegraMed supports its
provider networks with clinical and business information systems, marketing and
sales, facilities and operations management, finance and accounting, human
resources, legal, risk management and quality assurance services. IntegraMed
also offers treatment-financing programs for self-pay patients.

IntegraMed`s fertility network is the nations largest fertility network,
comprised of 36 contracted centers with over 100 locations in 31 states and the
District of Columbia. Nearly one of every four IVF procedures in the U.S. is
performed in an IntegraMed network fertility practice. The IntegraMed Vein Care
network is the leading provider of varicose vein care services in the US,
operating 34 centers in 13 states, principally in the Midwest and Southeast.

For more information about IntegraMed please visit:

www.integramed.com for investor background,

www.integramedfertility.com for fertility, or

www.veinclinics.com for vein care

Investors:
IntegraMed America, Inc.
John W. Hlywak, Jr., EVP and CFO, 914-251-4143
jhlywak@integramed.com
OR
Media/Investors:
Jaffoni & Collins Incorporated
Norberto Aja/David Collins, 212-835-8500
inmd@jcir.com

Copyright Business Wire 2009